The SARS-CoV-2 pandemic has prompted extensive developments in diagnostic testing and population surveillance, which are critical tools in mitigating viral spread. Strategies have evolved from ...

Basel, 6 December 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced its plans to launch the SARS-CoV-2 & Flu A/B Rapid Antigen Test for professional use in markets accepting the CE Mark by the ...

CARLSBAD, Calif., March 19, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the ...

Since its emergence as a novel pandemic in 2019, SARS-CoV-2 has become endemic worldwide. Accordingly, there is an ongoing market in antigen-based testing for this virus. Microbix's SARS-CoV-2 antigen ...

The granting of emergency use authorization by the U.S. FDA to Roche AG for its four-in-one molecular test for SARS-CoV-2, Influenza A/B viruses and respiratory syncytial virus will allow the company ...

Voluntary SARS CoV 2 testing of the hemodialysis population may require incentives beyond varying test frequency. Only 8% of patients voluntarily comply with repeat SARS-CoV-2 testing in hemodialysis ...

This study characterizes several novel activities of SARS-CoV-2 helicase nsp13, providing valuable insights into potentially new functions of this essential RNA-processing enzyme in the virus life ...